Paper39019010
Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model.
Amanna IJ and 14 others. Cell Rep Med, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model. Papers, record 39019010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39019010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydrogen Peroxide | Major topic |
| Macaca mulatta | Major topic |
| Vaccines, Inactivated | Major topic |
| Yellow Fever Vaccine | Major topic |
| Yellow Fever | Major topic |
| Yellow fever virus | Major topic |
| Antibodies, Neutralizing | Major topic |
| Antibodies, Viral | Major topic |
| Disease Models, Animal | Major topic |
| Animals | |
| Vaccines, Attenuated | |
| Chlorocebus aethiops | |
| Vero Cells | |
| Humans |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI073755 | NIAID NIH HHS | United States | R01AI073755 | PubMed and NIH | NIH RePORTER |
| DP5 OD029608 | NIH HHS | United States | DP5OD029608 | PubMed and NIH | NIH RePORTER |
| R44 AI079898 | NIAID NIH HHS | United States | R44AI079898 | PubMed and NIH | NIH RePORTER |
| P51 OD011092 | NIH HHS | United States | P51OD011092 | PubMed and NIH | NIH RePORTER |
| U54 AI081680 | NIAID NIH HHS | United States | U54AI081680 | PubMed and NIH | NIH RePORTER |
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10632996 | Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. | Trop Med Int Health | 1999 | https://conductscience.org/library/papers/10632996 | PubMed |
| 2 | 18398296 | Protective immunity following vaccination: how is it defined? | Hum Vaccin | 2008 | https://conductscience.org/library/papers/18398296 | PubMed |
| 3 | 22635006 | Development of a new hydrogen peroxide–based vaccine platform. | Nat Med | 2012 | https://conductscience.org/library/papers/22635006 | PubMed |
| 4 | 34577591 | The Present and Future of Yellow Fever Vaccines. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34577591 | PubMed |
| 5 | 24800812 | Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data. | PLoS Med | 2014 | https://conductscience.org/library/papers/24800812 | PubMed |
| 6 | 4984200 | Yellow fever virus. II. Factors affecting the plaque neutralization test. | Appl Microbiol | 1969 | https://conductscience.org/library/papers/4984200 | PubMed |
| 7 | 23028428 | A flow cytometry-based assay for quantifying non-plaque forming strains of yellow fever virus. | PLoS One | 2012 | https://conductscience.org/library/papers/23028428 | PubMed |
| 8 | 35788221 | Development of a next-generation chikungunya virus vaccine based on the HydroVax platform. | PLoS Pathog | 2022 | https://conductscience.org/library/papers/35788221 | PubMed |
| 9 | 17012873 | Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. | Hum Vaccin | 2006 | https://conductscience.org/library/papers/17012873 | PubMed |
| 10 | 28017559 | Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015-16: a modelling study. | Lancet Infect Dis | 2017 | https://conductscience.org/library/papers/28017559 | PubMed |
| 11 | 17316927 | Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005. | Vaccine | 2007 | https://conductscience.org/library/papers/17316927 | PubMed |
| 12 | 11803060 | Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. | Vaccine | 2002 | https://conductscience.org/library/papers/11803060 | PubMed |
| 13 | 7235133 | Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues. | Am J Trop Med Hyg | 1981 | https://conductscience.org/library/papers/7235133 | PubMed |
| 14 | 3944585 | Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses. | J Gen Virol | 1986 | https://conductscience.org/library/papers/3944585 | PubMed |
| 15 | 27919629 | Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine. | Vaccine | 2017 | https://conductscience.org/library/papers/27919629 | PubMed |
| 16 | 16908625 | Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. | J Exp Med | 2006 | https://conductscience.org/library/papers/16908625 | PubMed |
| 17 | 13923245 | Eczema vaccinatum treated with n-methylisatin beta-thiosemicarbazone. | Br Med J | 1962 | https://conductscience.org/library/papers/13923245 | PubMed |
| 18 | 33268494 | Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/33268494 | PubMed |
| 19 | 25862300 | An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures. | Vaccine | 2015 | https://conductscience.org/library/papers/25862300 | PubMed |
| 20 | 30346562 | Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers. | J Travel Med | 2018 | https://conductscience.org/library/papers/30346562 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41600981 | The Yellow Fever Vaccine Journey: Milestones and Future Directions. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41600981 | PubMed |
| 41032627 | An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaques. | Sci Transl Med | 2025 | https://conductscience.org/library/papers/41032627 | PubMed |
| 40904452 | Molecular ingredients of an immunogen for long-lasting IgG. | Front Immunol | 2025 | https://conductscience.org/library/papers/40904452 | PubMed |
| 40662744 | Lessons learned from successful implementation of tetanus and diphtheria vaccination programs. | Clin Microbiol Rev | 2025 | https://conductscience.org/library/papers/40662744 | PubMed |
| 40364846 | A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses. | Front Immunol | 2025 | https://conductscience.org/library/papers/40364846 | PubMed |
| 40284841 | Yellow Fever in Non-Human Primates: A Veterinary Guide from a One Health Perspective. | Vet Sci | 2025 | https://conductscience.org/library/papers/40284841 | PubMed |
| 39772058 | An Inactivated West Nile Virus Vaccine Candidate Based on the Lineage 2 Strain. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39772058 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39019010
GET https://conductscience.org/api/papers/v1/39019010/references?page=2